Navigation Links
Hologic Announces First Quarter Fiscal 2013 Operating Results
Date:2/4/2013

he prior year, an increase of 3.0%. The increase was driven primarily by an increase in MyoSure system sales, partially offset by a $5.1 million reduction in Adiana system revenues due to the Company's decision in the second quarter of fiscal 2012 to discontinue sales of that product line and, to a lesser extent, a slight decrease in NovaSure system sales. Excluding Adiana revenues in both periods, the increase in GYN Surgical revenues was approximately 10.1%.
  • Skeletal Health revenues totaled $23.7 million in the current quarter compared to $24.7 million in the prior year, a decrease of 4.1%. This decrease was primarily the result of a slight reduction in product and service revenues.
  • Publication of the Oslo Tomosynthesis Screening Trial Results: On January 7, 2013, results from the first large-scale, peer-reviewed prospective clinical study of its kind were published online, in advance of print, by Radiology, the Radiological Society of North America scientific journal. The researchers reported that the addition of Hologic's 3D mammography (breast tomosynthesis) screening technology to a 2D breast screening exam significantly increased cancer detection, particularly for invasive cancers, and simultaneously decreased the false-positive rates. Some of the significant findings reported include:

  • A 40% increase in the detection of invasive breast cancers
  • A 27% increase in the detection of all cancers (invasive and in situ cancers combined)
  • A 15% decrease in false‐positive rates
  • An increase in cancer detection across all breast tissue densities, from dense to fatty
  • All of the above achieved with no increase in the detection of ductal carcinoma in situ, which is non-invasive and cited as potentially being over-diagnosed.
  • New Products:APTIMA HPV 16 18/45 Genotype Assay for use on TIGRIS:

    On October 16, 2012, the Company announced FDA approval of its APTIMA HPV 16 18/45 Ge
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
    2. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
    3. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
    4. Hologic, Inc. Announces Note Offering
    5. Hologic And Gen-Probe Provide Update On Pending Transaction
    6. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
    7. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
    8. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
    9. Hologic Announces Third Quarter Fiscal 2012 Operating Results
    10. Hologic Completes Acquisition Of Gen-Probe
    11. Senator Blumenthal, a Strong Advocate for Womens Health, Visits Hologics Manufacturing Facility in Danbury, CT
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... Dec. 24, 2014  Actavis plc (NYSE: ... has received a complete response letter from the ... New Drug Application (NDA) for the fixed-dose combination ... of hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... in the receipt of a complete response letter, ...
    (Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
    (Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
    Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
    (Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
    (Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
    (Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
    (Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... , PHILADELPHIA, June 19 Kensey Nash Corporation (Nasdaq: ... and President, received the Ernst & Young Entrepreneur Of The ... in the greater Philadelphia region. According to Ernst & ... and leading dynamic, growing businesses. Joe Kaufmann was selected ...
    ... cases of E. coli infection in 28 states ... are warning consumers not to eat any Nestlé Toll House ... E. coli contamination. , In response to the Food ... was voluntarily recalling its Toll House refrigerated cookie dough items. ...
    ... ... which provides an invaluable service to many patients who need blood products. , ... Washington (Vocus) June 19, 2009 -- Children,s ... which provides an invaluable service to many patients who need blood products. Children,s National is ...
    ... levels in patients , FRIDAY, June 19 (HealthDay News) ... may explain brain gray matter reductions experienced by patients ... found an association between fibromyalgia and reductions in gray ... , In this new study, Dr. Patrick B. Wood, ...
    ... ARDEE, Ireland, June 19 Warner Chilcott Limited (Nasdaq: ... Wachovia,s 19th Annual Mid-Year Equity Conference on Wednesday, June 24, ... will be Rochelle Fuhrmann, Senior Director, Investor Relations. , ... interested parties at www.wcrx.com under the Investor Relations ...
    ... ... Control Spread of Infectious Diseases , ... Fargo, ND (PRWEB) June 19, 2009 - Last week, the World Health Organization declared ... state health officials in the U.S. are urging healthcare providers to take precautions to limit ...
    Cached Medicine News:Health News:Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region 2Health News:Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region 3Health News:Nestlé Recalls Cookie Dough Products 2Health News:Children's National Medical Center Dedicates New Blood Donor Center 2Health News:Children's National Medical Center Dedicates New Blood Donor Center 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 4
    ... Avaulta™ BioSynthetic Mesh ... mesh coated in the ... absorbable, hydrophilic film of ... segments of the Avaulta™ ...
    The Repliform Tissue Regeneration Matrix is an acellular human dermal allograft that when surgically implanted is intended to function as a template, facilitating the body's fibroblasts to regenerate...
    ... Pelvicol® Acellular Collagen Matrix delivers the ... exceptional strength, versatility, and durability in ... the effectiveness of site-specific defect repair ... sterile, biocompatible, crosslinked porcine dermal collagen ...
    ... The QIAamp Viral RNA ... viral nucleic acids from cell-free ... nucleic acids that can be ... but are not limited to, ...
    Medicine Products: